Prestige Consumer Healthcare Beats Fiscal Q2 2027 Estimates as Revenue Rises 23% to $336.3M

Prestige Consumer Healthcare (PBH) beat estimates for the fiscal second quarter of 2027 on both revenue and adjusted EPS. Revenue was $336.3 million, up 23% from a year earlier, above the $329.1 million estimate, and adjusted EPS was $1.13, up 5.6% from a year earlier, above the $1.07 estimate.

Shares fell 0.8% in premarket trading as of 6:00 a.m. ET, to $52.88 from a $53.28 close.

Fiscal Q2 2027 scorecard

By our calculation, revenue was $7.2 million above the estimate and adjusted EPS was $0.06 above it. The QoQ column compares with the previous quarter's revenue of $265.7 million and adjusted EPS of $0.98. The YoY column compares with $274.1 million and $1.07 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 5 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $274.1 million, $283.4 million, $281.6 million, $265.7 million and $336.3 million.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $1.23 and revenue of $351.7 million next quarter, based on 5 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 23% increase to $336.3 million.
• Estimate record. Whether Prestige Consumer Healthcare extends a record of beating EPS estimates in 5 of its last 8 reports.
• Related coverage. See our reports on GigaCloud Technology, First Advantage, EPAM Systems and Ducommun.

Sources: Results are from Prestige Consumer Healthcare's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Prestige Consumer Healthcare's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.